Literature DB >> 7668036

Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines.

A Mark1, B Björkstén, M Granström.   

Abstract

Immunoglobulin E responses to diphtheria and tetanus toxoids were investigated in pre- and postbooster samples of 104 children given, at 10 years of age, a DT booster with either an adsorbed (n = 51) or a non-adsorbed, fluid vaccine (n = 53). Vaccination with adsorbed DT is part of a national immunisation programme and represents the first regular booster given to these children, primarily immunised with three doses of adsorbed DT at age 3-6 months. The vaccines, with a content of 30 Lf of diphtheria toxoid and 7.5 Lf of tetanus toxoid per millilitre, were given for booster in a dose of 0.25 ml as a deep subcutaneous injection. In the prebooster samples, 3 and 14% had measurable IgE to diphtheria and tetanus, respectively. These rates rose to 94 and 92% in the postbooster samples, respectively. The median (range) of IgE to tetanus among recipients of the adsorbed vaccine was 0.59 PRU ml-1 (< 0.1-17.5), as compared to 0.27 (< 0.1-8.22) in the recipients of the fluid vaccine (p = 0.027). The median IgE response to diphtheria toxoid in the whole group was 1.8 (< 0.1-17.5), with no significant difference between the two vaccines (p = 0.76). There was no correlation between the IgE and IgG responses (r < 0.07, p > 0.5) but the two IgE responses as well as the ratios of IgG/IgE showed strong correlations (r > 0.7, p < 0.001). The study thus revealed unexpectedly high rates of IgE responses to diphtheria and tetanus toxoids in a regular DT booster vaccination programme, which were associated to high rates of local side effects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7668036     DOI: 10.1016/0264-410x(94)00017-h

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  Tetanus vaccination is associated with differential DNA-methylation: Reduces the risk of asthma in adolescence.

Authors:  Vimala Devi Janjanam; Nandini Mukherjee; Gabrielle A Lockett; Faisal I Rezwan; Ramesh Kurukulaaratchy; Frances Mitchell; Hongmei Zhang; Hasan Arshad; John W Holloway; Wilfried Karmaus
Journal:  Vaccine       Date:  2016-11-17       Impact factor: 3.641

3.  Immune response to varicella vaccine in children with atopic dermatitis compared with nonatopic controls.

Authors:  Lynda Schneider; Adriana Weinberg; Mark Boguniewicz; Patricia Taylor; Hans Oettgen; Lisa Heughan; Daniel Zaccaro; Brian Armstrong; Aaron Holliday; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2010-12       Impact factor: 10.793

4.  Influence of dose and frequency of antigen injection on IgE development in young children: a comparison of fire ant stings and tetanus immunizations.

Authors:  Dennis R Ownby; Megan E Partridge; Ganesa R Wegienka; Kimberley J Woodcroft; Edward L Peterson; Christine L M Joseph; L Keoki Williams; Christine C Johnson
Journal:  Ann Allergy Asthma Immunol       Date:  2009-10       Impact factor: 6.347

5.  The LTR72 mutant of heat-labile enterotoxin of Escherichia coli enhances the ability of peptide antigens to elicit CD4(+) T cells and secrete gamma interferon after coapplication onto bare skin.

Authors:  A-S Beignon; J-P Briand; R Rappuoli; S Muller; C D Partidos
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

6.  Efficiency of pH-sensitive fusogenic polymer-modified liposomes as a vaccine carrier.

Authors:  Shinobu Watarai; Tana Iwase; Tomoko Tajima; Eiji Yuba; Kenji Kono
Journal:  ScientificWorldJournal       Date:  2013-02-04

7.  Liposome-coupled antigens are internalized by antigen-presenting cells via pinocytosis and cross-presented to CD8 T cells.

Authors:  Yuriko Tanaka; Maiko Taneichi; Michiyuki Kasai; Terutaka Kakiuchi; Tetsuya Uchida
Journal:  PLoS One       Date:  2010-12-17       Impact factor: 3.240

8.  Booster vaccination: the role of reduced antigen content vaccines as a preschool booster.

Authors:  Giovanni Gabutti; Cecilia Trucchi; Michele Conversano; Giambattista Zivelonghi; Giorgio Zoppi
Journal:  Biomed Res Int       Date:  2014-02-11       Impact factor: 3.411

9.  Assessment of the adjuvant activity of mesoporous silica nanoparticles in recombinant Mycoplasma hyopneumoniae antigen vaccines.

Authors:  Veridiana Gomes Virginio; Natalia Costantin Bandeira; Fernanda Munhoz Dos Anjos Leal; Marcelo Lancellotti; Arnaldo Zaha; Henrique Bunselmeyer Ferreira
Journal:  Heliyon       Date:  2017-01-06

10.  A cross-sectional study of the relationship between reported human papillomavirus vaccine exposure and the incidence of reported asthma in the United States.

Authors:  David A Geier; Janet K Kern; Mark R Geier
Journal:  SAGE Open Med       Date:  2019-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.